Real-time insights. Smarter decisions. Better trades.
🔍 Search Stocks 14 day Free Trial
IMPEDIMED LIMITED (IPD)ASX AI Signals has generated 2 signal(s) for IPD during the last 90 days, indicating Moderate trading activity
Latest IPD Signals | |
| 26/05/2026 | BUY |
| 05/05/2026 | SELL |
IPD Share Price | |
| Current Price | $0.006 |
| 52 Week High | $0.057 |
| 52 Week Low: | $0.005 |
| Trading at (% of 52 Week High) | 10.53% |
Impedimed Limited (ASX: IPD) develops and markets bioimpedance measurement devices used for the detection and monitoring of lymphatic system disorders. Their technology helps healthcare professionals manage conditions such as lymphedema by providing accurate, non-invasive assessments. The company serves medical markets worldwide with a focus on improving patient outcomes.
The Health Care Equipment & Services sector on the ASX includes companies that produce medical devices, equipment, and supplies, as well as those providing healthcare-related services. This sector covers a wide range of products such as surgical instruments, diagnostic machines, and health monitoring devices. It also includes businesses involved in healthcare management, medical laboratories, and support services. These companies play a key role in supporting hospitals, clinics, and other healthcare providers to improve patient care. The sector is influenced by factors like technological advances, regulatory changes, and demand for healthcare services.
The BUY signal for IMPEDIMED LIMITED (IPD) is supported by potential growth in medical technology, but the extremely low stock price and limited liquidity increase risk, resulting in a low confidence level.
Former Hologic executive to lead next phase of growth
and commercial execution for medical technology leader
CARLSBAD, Calif., April 7, 2026 /PRNewswire/ --Â ImpediMed, a leader in the development and commercialization of medical technologies to clinically monitor and manage fluid and body composiLatest IMPEDIMED LIMITED(IPD) News
ImpediMed Appoints Erik Anderson as Chief Executive Officer
Get access to daily BUY & SELL signals, advanced AI analysis, watchlists and email alerts.
14 Day Free Trial • Cancel Anytime • Founders Price $15/month
Start My Free Trial